Cullen A, Mazhar MK, Smith MD, Lithander FE, Ó Breasail M, Henderson EJ. Wearable and Portable GPS Solutions for Monitoring Mobility in Dementia: A Systematic Review. Sensors. 2022 Jan;22(9):3336.

 

Ó Breasail M, Biswas B, Smith MD, Mazhar MK, Tenison E, Cullen A, Lithander FE, Roudaut A, Henderson EJ Wearable GPS and Accelerometer Technologies for Monitoring Mobility and Physical Activity in Neurodegenerative Disorders: A Systematic Review. Sensors. 2021 Dec 10;21(24):8261.

 

Smith MD, Brazier DE, Henderson EJ. Current Perspectives on the Assessment and Management of Gait Disorders in Parkinson’s Disease. Neuropsychiatric Disease and Treatment. 2021;17:2965.

 

Neumann S, Taylor J, Bamford A, Metcalfe C, Gaunt DM, Whone A, Steeds D, Emmett SR, Hollingworth W, Ben-Shlomo Y, Henderson EJ. Cholinesterase inhibitor to prevent falls in Parkinson’s disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson’s disease. BMC neurology. 2021 Dec;21(1):1-2.

 

Ypinga JH, Van Halteren AD, Henderson EJ, Bloem BR, Smink AJ, Tenison E, Munneke M, Ben-Shlomo Y, Darweesh SK. Rationale and design to evaluate the PRIME Parkinson care model: a prospective observational evaluation of proactive, integrated and patient-centred Parkinson care in The Netherlands (PRIME-NL). BMC neurology. 2021 Dec;21(1):1-1.

 

Neumann S, Bamford A, Lithander FE, Tenison E, Henderson EJ. Public attitudes to the use of remote data collection in clinical research. Contemporary Clinical Trials. 2021 Dec 1;111:106595.

 

Breasail MÓ, Smith MD, Tenison E, Henderson EJ, Lithander FE. Parkinson's disease: the nutrition perspective. Proceedings of the Nutrition Society. 2021 Oct 4:1-30.

 

Brock P, Oates LL, Gray WK, Henderson EJ, Mann H, Haunton VJ, Skelly R, Hand A, Davies ML, Walker RW. Driving and Parkinson’s Disease: A Survey of the Patient’s Perspective. Journal of Parkinson's disease. 2021 Sep 16(Preprint):1-7.

 

Brazier DE, Perneta N, Lithander FE, Henderson EJ. Prone Positioning of Older Adults with COVID-19: A Brief Review and Proposed Protocol. The Journal of Frailty & Aging. 2021 Aug 27:1-6.

 

Kobylecki C, Glasse H, Amin J, Gregson CL, Lyell V, Henderson EJ. Fracture risk assessment in atypical parkinsonian syndromes. Movement disorders clinical practice. 2021 Apr;8(3):385-9.

​

Pelicioni PH, Menant JC, Henderson EJ, Latt MD, Brodie MA, Lord SR. Mild and marked executive dysfunction and falls in people with Parkinson’s disease. Brazilian Journal of Physical Therapy. 2021 Jul 1;25(4):437-43.

​

Smith N, Gaunt DM, Whone A, Ben-Shlomo Y, Henderson EJ. The association between frailty and Parkinson’s disease in the ReSPOnD trial. Canadian Geriatrics Journal. 2021 Mar;24(1):22.

​

Neumann, Henderson EJ, EJ. A Snapshot of the Response from UK-based Clinical Trials of Investigational Medicinal Products to COVID-19. Cureus, 12(9) 2020.

​

Bamford A, Henderson EJ.. Parkinson's disease in older people. Medicine. 2021 Jan 1;49(1):56-61.

Tenison E, Henderson EJ. Multimorbidity and Frailty: Tackling Complexity in Parkinson’s Disease. Journal of Parkinson's Disease. 2020 Jan 1(Preprint):1-7.

​

Jones S, Torsney KM, Scourfield L, Berryman K, Henderson EJ. Neuropsychiatric symptoms in Parkinson's disease: aetiology, diagnosis and treatment. BJPsych Advances. 2020 Nov;26(6):333-42.

 

Lithander FE, Neumann S, Tenison E, Lloyd K, Welsh TJ, Rodrigues JC, Higgins JP, Scourfield L, Christensen H, Haunton VJ, Henderson EJ. COVID-19 in older people: a rapid clinical review. Age and ageing. 2020 Jul 1;49(4):501-15.

 

Tenison E, Smink A, Redwood S, Darweesh S, Cottle H, van Halteren A, van den Haak P, Hamlin R, Ypinga J, Bloem BR, Ben-Shlomo Y, Munneke M, Henderson EJ. Proactive and Integrated Management and Empowerment in Parkinson’s Disease: Designing a New Model of Care. Parkinson’s Disease. 2020 Mar 30;2020.

​

Lloyd K, Gaunt D, Haunton V, Skelly R, Mann H, Ben-Shlomo Y, Henderson EJ. Driving in Parkinson’s disease: a retrospective study of driving and mobility assessments. Age and Ageing. 2020 Jun 25.

​

Bloem BR, Henderson EJ, Dorsey ER et al. Integrated and patient-centred management of Parkinson's disease: a network model for reshaping chronic neurological care. The Lancet Neurology. 2020 May 25.

​

Lord SR, Bindels H, Ketheeswaran M, Brodie MA, Lawrence AD, Close JC, Whone AL, Ben-Shlomo Y, Henderson EJ. Freezing of Gait in People with Parkinson’s Disease: Nature, Occurrence, and Risk Factors. Journal of Parkinson's Disease. 2020 Jan 1(Preprint):1-0.

​

Smith N, Brennan L, Gaunt DM, Ben-Shlomo Y, Henderson EJ. Frailty in Parkinson’s disease: a systematic review. Journal of Parkinson's disease. 2019 Jan 1;9(3):517-24.

​

Smith MD, Ben-Shlomo Y, Henderson EJ. How often are patients with progressive supranuclear palsy really falling? Journal of neurology. 2019 May 23:1-2.

​

Henderson EJ, Lyell V, Bhimjiyani A, Amin J, Kobylecki C, Gregson CL. Management of fracture risk in Parkinson's: A revised algorithm and focused review of treatments. Parkinsonism & related disorders. 2019 Apr 8.

​

Henderson EJ, Morgan GS, Amin J, Gaunt DM, Ben-Shlomo Y. The minimum clinically important difference (MCID) for a falls intervention in Parkinson's: A delphi study. Parkinsonism & related disorders. 2019 Apr 1;61:106-10.

​

Radder DL, de Vries NM, Riksen NP, Diamond SJ, Gross D, Gold DR, Heesakkers J, Henderson EJ, Hommel AL, Lennaerts HH, Busch J. Multidisciplinary care for people with Parkinson’s disease: the new kids on the block!. Expert review of neurotherapeutics. 2019 Feb 1.

​

Whateley JM, Huffman AJ, Henderson EJ. Acute inability to mobilise resulting from probable donepezil-induced myoclonus. Age and Ageing. 2018 Jun 23.

​

Henderson EJ, Chu H, Gaunt DM, Whone AL, Ben-Shlomo Y, Lyell V. Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson’s Disease. Parkinson’s Disease. 2016 Jul 5;2016.

​

Smith N, Fackrell R, Henderson EJ. Ciprofloxacin-associated bilateral iliopsoas tendon rupture: a case report. Age and ageing. 2016 May 23:afw092.

​

Henderson EJ, Lord SR, Brodie MA, Gaunt DM, Lawrence AD, Close JC, Whone AL, Ben-Shlomo Y. Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet Neurology. 2016 Jan 13.

​

Lyell V, Henderson EJ, Devine M, Gregson C. Assessment and management of fracture risk in patients with Parkinson's disease. Age and ageing 2014 Sep 18 10.1093/ageing/afu122.

​

Henderson EJ, Lord SR, Close JC, Lawrence AD, Whone A, Ben-Shlomo Y. The ReSPonD trial-rivastigmine to stabilise gait in Parkinson’s disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson’s disease who have fallen. BMC neurology. 2013 Dec 3;13(1):1.

​

Tinkler M, Lyons E, Henderson EJ. An Unusual Cause of Confusion: Hepatic Encephalopathy in Hereditary Haemorrhagic Telangectasia. European Journal of General Medicine. 2013 Feb 16;9(4).

​

Henderson EJ, Drake M. Overactive bladder. Maturitas. 2010 Jul 1;66(3):257-62.

Henderson EJ, Caplan GA. Home sweet home? Community care for older people in Australia. Journal of the American Medical Directors Association. 2008 Feb 1;9(2):88-94.